17:33:07 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



C:LOBE - Lobe Sciences Ltd. - http://www.lobesciences.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
LOBE - C  213.00.015·0.025116.40.015-0.01-40.010.0030.015  0.015  0.0150.04  0.0109:33:09Apr 2915 min RT 2¢
CSE - C213.00.015·0.025116.40.015-0.01-40.010.0030.015  0.015  0.0150.04  0.0109:33:0915 min

Recent Trades - All 3 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
09:33:09C0.015-0.018,0002 RBC7 TD SecK
09:33:09C0.015-0.011,0002 RBC7 TD SecK
09:33:09C0.015-0.011,0007 TD Sec7 TD SecK
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-29 19:00C:LOBE0.02SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-04-29 18:35C:LOBE0.02SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-20 19:26C:LOBE0.02SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-20 19:26C:LOBE0.02SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-15 12:04C:LOBE0.02SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-02-15 12:04C:LOBE0.02SEDAR MD & ASEDAR MD & A
2024-01-08 12:06C:LOBE0.02News ReleaseLobe Sciences reviews 2023 activities
2023-12-07 10:09C:LOBE0.02News ReleaseLobe Sciences talks results of phase 1 L-130 trial
2023-12-05 09:56C:LOBE0.025News ReleaseLobe's psilocin compound shelf stable 12 months
2023-09-18 13:55C:LOBE0.02News ReleaseLobe Sciences appoints Lee as CFO
2023-09-14 18:13C:LOBE0.02News ReleaseLobe amends share purchase deal with Altemia
2023-08-01 13:42C:LOBE0.025SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-01 02:36C:LOBE0.03News ReleaseLobe Sciences clarifies Altemia acquisition disclosure
2023-06-27 10:47C:LOBE0.025News ReleaseLobe Sciences begins phase 1 clinical trial of L-130
2023-06-07 11:38C:LOBENews ReleaseLobe Sciences appoints Phillips as COO
2023-05-17 13:02C:LOBE0.035News ReleaseLobe Sciences, Pentec to roll out Altemia in U.S.